Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The corporate coauthor.

Adriane Fugh-Berman1

  • 1Department of Physiology and Biophysics, Georgetown University School of Medicine, Washington, DC 20051-1460, USA. ajf29@georgetown.edu

Journal of General Internal Medicine
|July 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of menopausal hormone therapy on cardiovascular disease, cancer, cognition and depression in younger women: A systematic review.

JRSM open·2026
Same author

Redefining Pain and Addiction: How Opioid Manufacturers Changed Medical Language to Foster Opioid Use.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
Same author

Menopausal Hormone Therapy: Limited Benefits, Significant Harms.

American family physician·2025
Same author

Does menopause hormone therapy prevent Alzheimer's disease and dementia?

Drug and therapeutics bulletin·2024
Same author

Parkinson's Disease Psychosis and the Marketing of Pimavanserin.

International journal of social determinants of health and health services·2024
Same author

Are New Alzheimer Drugs Better Than Older Drugs?

JAMA internal medicine·2023

Pharmaceutical companies use ghostwritten articles and subtle marketing to influence medical journals. Current conflict of interest disclosures are insufficient, necessitating a public database for transparency.

Area of Science:

  • Medical Journalism
  • Pharmaceutical Marketing
  • Academic Ethics

Background:

  • Drug marketing strategies increasingly involve sponsoring articles in peer-reviewed journals.
  • Ghostwriters, employed by pharmaceutical or medical education companies, may author or co-author these sponsored articles.
  • Subtle marketing tactics, such as creating perceived drug need or criticizing competitors, obscure conflicts of interest.

Purpose of the Study:

  • To examine the methods used in drug marketing through sponsored medical journal articles.
  • To assess the adequacy of current conflict of interest (COI) disclosure standards.
  • To propose improvements for detecting and managing COIs in medical publications.

Main Methods:

  • Analysis of drug marketing techniques involving sponsored publications.
Keywords:
Biomedical and Behavioral Research

Related Experiment Videos

  • Review of existing voluntary standards for COI declarations.
  • Identification of challenges in detecting undeclared conflicts.

    • Main Results:

    • Sponsored articles, sometimes ghostwritten, are a prevalent drug marketing technique.
    • Conflicts of interest are difficult to detect, especially when articles focus on need or competition rather than the drug itself.
    • Current voluntary COI disclosure standards are inadequate for medical journals and conferences.

    Conclusions:

    • Existing voluntary standards for disclosing conflicts of interest are insufficient.
    • A public database of physician and researcher conflicts of interest is needed.
    • Enhanced transparency is crucial to maintain the integrity of medical literature and presentations.